[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioCentury Avatar @BioCentury BioCentury

BioCentury posts on X about kong, hong kong, finance, $192m the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance travel destinations stocks

Social topic influence kong, hong kong, finance, $192m, asia, $1530hk, investment, $7475m, $15b, ipos

Top accounts mentioned or mentioned by @usfda @usfdas @steveusdin1 @jeff_cranmer @fishburnsimone @stephenphansen @oppenheimer @novartis @vertexpharmas @biobonanos @marketwirenews @jnjnews @biauk @daniellegolovin @sareptas @lillypad @cmsgov @novonordisk @pfizer @abbvies

Top assets mentioned Novartis AG (NVS)

Top Social Posts #


Top posts by engagements in the last XX hours

"Third patient dies from acute liver failure caused by a Sarepta gene therapy"
@BioCentury Avatar @BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 93.2K engagements

"Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report"
@BioCentury Avatar @BioCentury on X 2025-07-18 21:30:12 UTC 16.3K followers, XXX engagements

"In BioCentury's Public Equity Report: Amid a difficult stretch for IPOs Nanjing Leads Biolabs has priced a HK$1.5B offering in Hong Kong; plus Abivax's $747.5M follow-on Pfizer's investment in 3SBio and more"
@BioCentury Avatar @BioCentury on X 2025-07-25 20:30:12 UTC 16.3K followers, XXX engagements

"BioCentury's latest biopharma Management Moves: Steve Bates longtime head of BIA named executive chair of U.K.s Office of Life Sciences. Plus: Novartis names Mazuk chief patient experience officer and updates from Seres and ABPI"
@BioCentury Avatar @BioCentury on X 2025-07-22 22:30:04 UTC 16.3K followers, XXX engagements

"In BioCentury's Venture Report: Australia's Brandon Capital closed its sixth fund at A$439M far outsizing the firm's previous vehicles; plus Dispatch's $216M launch and more"
@BioCentury Avatar @BioCentury on X 2025-07-24 23:00:07 UTC 16.3K followers, XXX engagements

"Seed/Series A money up in 1H25 but mostly a few companies raising monster rounds: a BioCentury Data Byte"
@BioCentury Avatar @BioCentury on X 2025-07-18 19:30:10 UTC 16.3K followers, XXX engagements